Company / Income Tax
Kiniksa Pharmaceuticals International, plc Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$29.9M
FY2025
5-year range
-$172.3M / $29.9M
FY2021-FY2025
Trend
+324.1%
vs FY2024
Sector context
#32 of 204
Health Care
What the data says
Income Tax changed +324% YoY in FY2025, a notable deviation from the 8-year average annual change of -2404%.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +42.1%. Top quartile in the Health Care sector.
Increased from -$31M to $30M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +42.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 204This company $29.9M Sector average $118.7M
▼
-74.8% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's income tax has grown for 3 consecutive years.
- 5-year CAGR of +42.1%, indicating consistent growth.
- In FY2025, income tax increased 324.1% year-over-year.
- Ranks #32 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.9M | +324.1% |
| FY2024 | $7.0M | +122.9% |
| FY2023 | -$30.7M | +82.2% |
| FY2022 | -$172.3M | -8319.0% |
| FY2021 | -$2.0M | -139.7% |
| FY2020 | $5.2M | +351.7% |
| FY2019 | -$2.0M | -856.5% |
| FY2018 | -$214.0K | -10800.0% |
| FY2017 | $2.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026